CompoAtlas

PALMITOYLETHANOLAMIDE

Natural health product licensed in Canada

Other names
Basis, Ortho Basis, Ortho Pain Relief, P.E.A, P.E.A Activate, P.E.A Bliss, P.E.A Boost, P.E.A Elite, P.E.A Pain Relief, P.E.A Relief, PEA, PEA Chewables, PEA Tablet, Palmitoylethanolamide Chewables, Pro InflammCore, Pro Pain Manager, Pro Pain Relief, Pro Palmitoylethanolamide (P.E.A)
Licence holder
Advanced Orthomolecular Research Inc.
NPN or DIN-HM
80095127
Status
Active licence
Licence date
31 October 2019
Revision date
Not provided
Form
Comprimé, à croquer
Route of administration
Orale
Application type
Non traditionnelle

If this product were sold in France

No point flagged by the rules we apply.

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
N-(2-Hydroxyéthyl)hexadécanamide

Source : Palmitoyléthanolamide

600 mgNot calculated

Non-medicinal ingredients

Hydroxypropylcellulose, Sirop de riz brun, Cellulose, Stéaryl fumarate de sodium, Xylitol, Eau distillée

PopulationAgeQuantity per servingFrequency
Adultesminimum: 19 years1 Comprimé2 Tous les jours

Uses authorised in Canada

Studies show that PEA may be used as an anti-inflammatory to help relieve chronic pain.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

Source

Official Health Canada record, licence 80095127

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Enter to analyse, Shift+Enter for a new line